newscontact us

Our Laboratories

Fortis-TotipotentRX Centre for Cellular Medicine

Fortis

The Fortis-TotipotentRX Cell Therapy and Cell Production Facility is a state-of-the-art resource that provides support to TotipotentRX’s ( a subsidiary of Cesca Therapeutics) clinical trial team, our subsidiary NovaCord Cord Blood Bank, Fortis Healthcare’s Bone Marrow Transplant Team, and the Fortis Healthcare investigators who are conducting Phase Ib and Phase II clinical trials that require cellular manufacturing for stem cell based therapies and adoptive immunotherapies. The scope of activities includes the purification of autologous and allogeneic stem cells, non-genetically engineered patient and donor cells, clinical cell purification, and extensive QA/QC oversight. The entire facility is housed within a brand new state of the art multi-specialty Fortis healthcare research hospital, and is designed to enhance patient safety and to meet the current Good Manufacturing Practices requirements of the U.S.Food and Drug Administration, WHO, and EMEA

Summary:

Services:                Bone Marrow Transplantation, Clinical Research, Cord Blood/Tissue
                                Banking
Capabilities:         Cell Expansion/manipulation, Biobanking, Cryopreservation,
                                Cellular Diagnostics, Imaging, Clinical Research
Design:                  Integrated, Intra-Hospital, Multi-Suite Cellular Manufacturing Facility,
                                Air Quality : ISO Class 7
Accreditations:    cGMP, cGCP, cGLP, ISO9001 (BSI), US FDA Registered

 

Cesca Therapeutics Emeryville Clinical R&D Facility

Emeryville_Lab2-01The Cesca Emeryville Clinical R&D Facility is located in the heart of San Francisco’s premier scientific talent basin.  This region can boast some of the most innovative developments in recent times from disciplines including scientific, medical (biotechnology and pharmaceutical) and information technologies.  The San Francisco bay area is home to world renowned institutions including Stanford University, UCSF, UC Berkeley amongst others and is also home to many majors in the biotechnology and regenerative medicine market space.  Within this region, Cesca has recently opened its Clinical R&D facility for pre-clinical and clinical data production in support of it major clinical trials initiatives.  Our facility contains an advanced regenerative medicine research laboratory equipped with instrumentation specific to biologic (cellular) research and a team with expertise in cellular technology ranging from research through clinical translation.

Summary:

Capabilities:        Cell Therapy Research & Development
Design:                 Laboratory and Cell Culture Facility

 

Fortis is a trademark of Fortis Healthcare Ltd.